ArticleJACC. Case reports2025
Advanced Heart Failure Therapies in Carceral Settings: LVAD Evaluation in an Incarcerated Patient.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
clinical conditionEvaluation for advanced heart failure (HF) therapy, including left ventricular assist device (LVAD) placement, in an incarcerated patient. KEY QUESTIONS: The key questions are the following: 1) how does incarceration impact cardiovascular risk?; 2) how does incarceration affect advanced HF therapy evaluation, and what legal and ethical considerations apply?; 3) what are the logistical challenges of managing LVAD therapy in the carceral setting?; and 4) what legal pathways exist for medically complex incarcerated patients, and how can clinicians advocate effectively on their behalf? OUTCOME: The patient was approved for LVAD placement. Shortly before LVAD implantation, he was approved for medical parole. He successfully underwent LVAD placement, was discharged home, and is now undergoing evaluation for heart transplantation. TAKE-HOME MESSAGES: Incarceration should not exclude patients from advanced HF therapies. Medical parole should be considered when ongoing care exceeds a facility's capabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.